1. Home
  2. SRCE vs IMCR Comparison

SRCE vs IMCR Comparison

Compare SRCE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 1st Source Corporation

SRCE

1st Source Corporation

HOLD

Current Price

$73.60

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$31.24

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRCE
IMCR
Founded
1863
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
SRCE
IMCR
Price
$73.60
$31.24
Analyst Decision
Hold
Buy
Analyst Count
4
10
Target Price
$73.25
$66.33
AVG Volume (30 Days)
134.5K
397.6K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
2.15%
N/A
EPS Growth
19.59
30.39
EPS
6.41
N/A
Revenue
N/A
$249,428,000.00
Revenue This Year
$10.29
$14.57
Revenue Next Year
$3.16
$8.21
P/E Ratio
$11.58
N/A
Revenue Growth
N/A
43.05
52 Week Low
$53.63
$27.06
52 Week High
$75.16
$40.71

Technical Indicators

Market Signals
Indicator
SRCE
IMCR
Relative Strength Index (RSI) 68.71 49.67
Support Level $65.26 $31.08
Resistance Level N/A $31.65
Average True Range (ATR) 1.42 1.15
MACD 0.44 0.18
Stochastic Oscillator 82.40 59.80

Price Performance

Historical Comparison
SRCE
IMCR

About SRCE 1st Source Corporation

1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: